A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

I Miller; Carina Lynggaard; Søren Nymand Lophaven; Claus Otto Carl Zachariae; D N Dufour; G B E Jemec

doi:10.1111/j.1365-2133.2011.10339.x

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

I Miller, Carina Lynggaard, Søren Nymand Lophaven, Claus Otto Carl Zachariae, D N Dufour, G B E Jemec

Afdeling for Allergi, Hud- og Kønssygdomme HGH

194 Citationer (Scopus)

Abstract

Hidradenitis suppurativa (HS) has an impact on patients' quality of life. Treatment of HS is generally unsatisfactory, thus new treatments are needed.

Originalsprog	Engelsk
Tidsskrift	British Journal of Dermatology
Vol/bind	165
Udgave nummer	2
Sider (fra-til)	391-8
Antal sider	8
ISSN	0007-0963
DOI	https://doi.org/10.1111/j.1365-2133.2011.10339.x
Status	Udgivet - 2011

Adgang til dokumentet

10.1111/j.1365-2133.2011.10339.x

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{4e4b560af8b54aa592e692b779dcc9d7,

title = "A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa",

abstract = "Hidradenitis suppurativa (HS) has an impact on patients' quality of life. Treatment of HS is generally unsatisfactory, thus new treatments are needed.",

keywords = "Adult, Anti-Inflammatory Agents, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Double-Blind Method, Female, Hidradenitis Suppurativa, Humans, Injections, Subcutaneous, Male, Middle Aged, Pain, Pain Measurement, Prospective Studies, Quality of Life, Treatment Outcome",

author = "I Miller and Carina Lynggaard and Lophaven, \{S{\o}ren Nymand\} and Zachariae, \{Claus Otto Carl\} and Dufour, \{D N\} and Jemec, \{G B E\}",

note = "{\textcopyright} 2011 The Authors. BJD {\textcopyright} 2011 British Association of Dermatologists 2011.",

year = "2011",

doi = "10.1111/j.1365-2133.2011.10339.x",

language = "English",

volume = "165",

pages = "391--8",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

AU - Miller, I

AU - Lynggaard, Carina

AU - Lophaven, Søren Nymand

AU - Zachariae, Claus Otto Carl

AU - Dufour, D N

AU - Jemec, G B E

PY - 2011

Y1 - 2011

N2 - Hidradenitis suppurativa (HS) has an impact on patients' quality of life. Treatment of HS is generally unsatisfactory, thus new treatments are needed.

AB - Hidradenitis suppurativa (HS) has an impact on patients' quality of life. Treatment of HS is generally unsatisfactory, thus new treatments are needed.

KW - Adult

KW - Anti-Inflammatory Agents

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Double-Blind Method

KW - Female

KW - Hidradenitis Suppurativa

KW - Humans

KW - Injections, Subcutaneous

KW - Male

KW - Middle Aged

KW - Pain

KW - Pain Measurement

KW - Prospective Studies

KW - Quality of Life

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/79960622489

U2 - 10.1111/j.1365-2133.2011.10339.x

DO - 10.1111/j.1365-2133.2011.10339.x

M3 - Journal article

C2 - 21457202

SN - 0007-0963

VL - 165

SP - 391

EP - 398

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater